HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity

HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity is a paper indexed in ScholarIQ from OpenAlex.

How many citations does HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity have?

HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity has 333 citations in the OpenAlex counts ScholarIQ stores.

When was HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity published?

HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity has 2018 year in the ScholarIQ index.

What is the open-access status of HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity?

HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity has closed oa status in the ScholarIQ index.

What is the DOI of HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity?

The DOI for HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity is on the source record.

What is the PMID of HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity?

The PMID for HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity is on the source record.

What is the OpenAlex record for HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity?

The OpenAlex for HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity is on the source record.